| New from NCI |
| NCI COVID-19 in Cancer Patients Study |
 | | Learn about the NCI COVID-19 in Cancer Patients Study (NCCAPS), a natural history study of COVID-19 in people with cancer. The knowledge gained from this study will help doctors better manage treatment for people with cancer and COVID-19. |
| For Women with Breast Cancer, Regular Exercise May Improve Survival |
 | | A new study adds to the body of research linking exercise and longer survival in some women with breast cancer. Read about how being physically active is one way that survivors can improve their health. |
| Nutrition Label Updated |
 | | The Nutrition Facts label that is displayed on food packages has been updated for the first time in 20 years. Learn how the label has changed to reflect the latest science, including links between nutrition and disease. |
Video—Cancer and Other Illnesses during COVID-19: How young patients and families can cope
If you missed the live broadcast, you can now watch the recording of our Facebook Live event. Listen to our panel of experts discuss ways young people with cancer or other serious illnesses and their families can cope with the added stress of the COVID-19 pandemic.
|
| FDA Approvals |
New Treatment for Metastatic Lung Cancer
We’ve updated our drug summaries for nivolumab (Opdivo) and ipilimumab (Yervoy). The Food and Drug Administration (FDA) approved this drug combination as first-line therapy for certain adults with metastatic non-small cell lung cancer that has the PD-L1 protein. |
New Treatments for Prostate Cancer
We’ve updated our drug summaries for olaparib (Lynparza) and rucaparib (Rubraca). FDA recently approved these drugs for treatment of adults with prostate cancer that has spread, has certain germline or somatic mutations, and has not responded to treatments that lower testosterone levels. |
No hay comentarios:
Publicar un comentario